Geode Capital Management, LLC Immunity Bio, Inc. Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,289,420 shares of IBRX stock, worth $12.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,289,420

Previous 3,840,918 11.68%

Holding current value

$12.3 Million

Previous $9.83 Million 31.32%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$2.32 - $3.9 $1.04 Million - $1.75 Million	448,502 Added 11.68%	4,289,420 $12.9 Million
Q4 2024 Feb 12, 2025	SELL	$2.56 - $6.17 $14,737 - $35,520	-5,757 Reduced 0.15%	3,840,918 $9.83 Million
Q3 2024 Nov 12, 2024	SELL	$3.32 - $6.7 $235,119 - $474,487	-70,819 Reduced 1.81%	3,846,675 $14.3 Million
Q2 2024 Aug 09, 2024	BUY	$4.82 - $9.15 $2.1 Million - $3.99 Million	436,108 Added 12.53%	3,917,494 $24.8 Million
Q1 2024 May 13, 2024	BUY	$3.23 - $6.17 $329,208 - $628,858	101,922 Added 3.02%	3,481,386 $18.7 Million
Q4 2023 Feb 13, 2024	BUY	$1.25 - $5.21 $716,601 - $2.99 Million	573,281 Added 20.43%	3,379,464 $17 Million
Q3 2023 Nov 13, 2023	BUY	$1.29 - $3.1 $97,692 - $234,766	75,731 Added 2.77%	2,806,183 $4.74 Million
Q2 2023 Aug 11, 2023	BUY	$1.53 - $6.41 $1.2 Million - $5.03 Million	784,588 Added 40.32%	2,730,452 $7.59 Million
Q1 2023 May 15, 2023	SELL	$1.35 - $4.78 $114,247 - $404,521	-84,628 Reduced 4.17%	1,945,864 $3.54 Million
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $473,728 - $737,273	108,903 Added 5.67%	2,030,492 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $1.27 Million - $2.24 Million	348,755 Added 22.17%	1,921,589 $9.55 Million
Q2 2022 Aug 12, 2022	BUY	$2.68 - $6.14 $66,514 - $152,388	24,819 Added 1.6%	1,572,834 $5.85 Million
Q1 2022 May 13, 2022	SELL	$5.05 - $7.53 $43,359 - $64,652	-8,586 Reduced 0.55%	1,548,015 $8.68 Million
Q4 2021 Feb 11, 2022	BUY	$5.67 - $10.18 $228,756 - $410,712	40,345 Added 2.66%	1,556,601 $9.46 Million
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $426,955 - $663,014	46,560 Added 3.17%	1,516,256 $14.8 Million
Q2 2021 Aug 13, 2021	BUY	$13.41 - $22.4 $10.8 Million - $18 Million	805,147 Added 121.16%	1,469,696 $21 Million
Q1 2021 May 12, 2021	BUY	$12.83 - $42.25 $8.53 Million - $28.1 Million	664,549 New	664,549 $15.8 Million

Others Institutions Holding IBRX

# of Institutions

239

Shares Held

79.9M

Call Options Held

1.08M

Put Options Held

2.73M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.15B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Immunity Bio, Inc. Transaction History